Etiometry Honored at Pediatric Cardiac Intensive Care Society Conference
News and Press Releases
BOSTON, December 23, 2014 — Etiometry received a “Top Abstract” award at the 2014 Pediatric Cardiac Intensive Care Society (PCICS) Conference. Our abstract reported the first retrospective study of the Risk Analytics technology, and was selected out of more than 200 abstracts submitted to the conference. We would like to thank our co-authors, Dr. Melvin Almodovar from Boston Children’s Hospital, and Dr. Peter Laussen from Toronto Sick Kids Hospital.
The abstract, titled “Risk Analytics and Outcome Prediction in Neonates Following Cardiac Surgery” assessed the ability of the Risk Analytics to predict a composite poor outcome and biomarkers for inadequate oxygen delivery. The study was conducted on 274 neonates who had undergone cardiac surgery within the first 30 days of life – a population which costs the U.S. healthcare system approximately $1.4B a year, and represent some of the most difficult patients to manage in the ICU.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]
Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking
BOSTON, Mass. – April 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool. Cardiogenic shock remains a critical challenge, with delayed identification […]
Boston Children’s enhances care with clinical intelligence platform
At Boston Children’s Hospital, Dr. Peter Laussen and Dr. Joshua Salvin are leading the way as true pioneers in clinical intelligence and AI. Through ongoing collaboration, their work has evolved to better integrate and interpret complex patient data, helping care teams shift toward more informed, data-driven decision-making in real time. Read how they helped shape […]